Back To Search Instructions
9 protocols meet the specified criteria
Disease Site: Brain and Nervous System
Protocol No.TitleStatus
0600000199Phase III Randomized Study of Chimeric Antibody 14.18 (CH14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell RescueOpen
0600000250A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy in Children with Newly Diagnosed Standard Risk MedulloblastomaOpen
0600000406A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma-Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated with Chemotherapy and PrednisoneOpen
0800000071COG ANBL0531: Response and Biology-Based Therapy for Intermediate-Risk NeuroblastomaOpen
0800000327COG ANBL0532 Phase III Randomized Trial of Single vs. Tandem Myeloablative Consolidation Therapy for High-Risk NeuroblastomaOpen
1300000005RTOG 1205 Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation versus Bevacizumab Alone as Treatment for Recurrent GlioblastomaOpen
1312169092A Pilot Study of the Combination of Nab-paclitaxel, Temozolomide and Bevacizumab in Patients with Metastatic Melanoma with Brain MetastasesOpen
1405321741Phase II Double-Blinded Placebo-Controlled Study of Bevacizumab with or without AMG 386 in Patients with Recurrent Glioblastoma or Gliosarcoma (RTOG 1122) Open
22745NCCTG N107C/Endorsed Study: A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease (RTOG 1270) Open